Tyloxapol-Echemi
20 Inquiries
25301-02-4
Pharmaceutical Grade
Any China Port
1 kg/ Bottle
2024-12-06
API,Intermediate
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Ethylene oxide-formaldehyde-4-(1,1,3,3-tetramethylbutyl)phenol copolymer
Other Name:Formaldehyde,polymer with oxirane and 4-(1,1,3,3-tetramethylbutyl)phenol;Phenol,p-(1,1,3,3-tetramethylbutyl)-,polymer with ethylene oxide and formaldehyde;Ethylene oxide,polymer with formaldehyde and p-(1,1,3,3-tetramethylbutyl)phenol;Oxirane,polymer with formaldehyde and 4-(1,1,3,3-tetramethylbutyl)phenol;Phenol,4-(1,1,3,3-tetramethylbutyl)-,polymer with formaldehyde and oxirane;Triton WR 1339;Tyloxapol;Alevaire;Oxyethylated tertiary octyl-phenol-formaldehyde polymer;Superinone;Triton A 20;p-Isooctylpolyoxyethylenephenol formaldehyde polymer;Ethylene oxide-formaldehyde-p-octylphenol copolymer;NSC 90255;Ethylene oxide-formaldehyde-4-(1,1,3,3-tetramethylbutyl)phenol copolymer;9014-50-0;9015-10-5;9014-66-8
CAS No.:25301-02-4
Molecular Formula:(C14H22O.C2H4O.CH2O)x
InChIKeys:InChIKey=MDYZKJNTKZIUSK-UHFFFAOYSA-N
Molecular Weight:137.17904
Exact Mass:280.20384475 g/mol
DSSTox ID:DTXSID30179950
ATC Code:R - Respiratory system
HScode:29222990
Categories:
Characteristics-
PSA:
49.83000
XLogP3:4.57360
Appearance:Clear to hazy yellow to amber Viscous Liquid
Density:1.1
Boiling Point:282.3ºC at 760 mmHg
Flash Point:113 °C
Hazard IdentificationClassification of the substance or mixture
Skin irritation, Category 2
Eye irritation, Category 2
Specific target organ toxicity â single exposure, Category 3
Reproductive toxicity, Category 2
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H315 Causes skin irritation
H319 Causes serious eye irritation
H335 May cause respiratory irritation
H361 Suspected of damaging fertility or the unborn child
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
P203 Obtain, read and follow all safety instructions before use.
Response P302+P352 IF ON SKIN: Wash with plenty of water/...
P321 Specific treatment (see ... on this label).
P332+P317 If skin irritation occurs: Get medical help.
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P319 Get medical help if you feel unwell.
P318 IF exposed or concerned, get medical advice.
Storage P403+P233 Store in a well-ventilated place. Keep container tightly closed.
P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
API,Intermediate
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
30
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
About Echemi Pharmaceutical
Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.
Advantage for Pharmaceutical
• Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.
• We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.
• We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.
Product Category
We care for human and animal health and we are committed to creating a better social environment.
• Human API
• Intermediate
• Veterinary API
• Agrochemical
• Fine Chemical
• Custom Synthesis
-
-
Inquiry History20 Inquiries
Country Product Purchase Quantity Date Posted 
India
TYLOXAPOL
50 KG Dec 16, 2024
India
TYLOXAPOL
50 KG Feb 5, 2025
India
TYLOXAPOL
50 KG Jan 10, 2025
India
TYLOXAPOL
5 KG May 23, 2025
India
TYLOXAPOL
50 KG Jul 2, 2025
India
TYLOXAPOL
25 KG May 26, 2025 
Canada
Tyloxapol
500 G May 9, 2026
India
Tyloxapol
2 KG Jun 30, 2026
India
Tyloxapol
100 KG Feb 11, 2026 
Pakistan
TYLOXAPOL
1 20' Fcl Jan 4, 2026
India
Tyloxapol
5 KG May 20, 2025
India
Tyloxapol
30 KG Jan 24, 2024
India
Tyloxapol
25 KG Jul 22, 2025
India
TYLOXAPOL
10 KG Jun 27, 2025
India
TYLOXAPOL
50 KG Feb 1, 2025
India
Triton WR 1339
50 G Jan 22, 2026
India
Tyloxapol USP
5.00 KG Nov 19, 2025
Pakistan
tyloxapol
500 G Oct 30, 2025
India
Tyloxapol
25 KG Jul 9, 2025 
France
Tyloxapol
100 KG Feb 18, 2025 Post an enquiry for this product
